This document discusses overactive bladder and compares the drug propiverine hydrochloride to previous anticholinergic agents for treating overactive bladder symptoms. It summarizes that propiverine has dual action as both an anticholinergic and calcium channel blocker. A clinical study of 73 patients compared propiverine to previous anticholinergic treatments and found that patients who completed the study on propiverine saw significant improvements in nighttime urinary frequency, urgency, and urgency incontinence. The document concludes that propiverine may be more effective than previous anticholinergic agents for some patients with overactive bladder.